|
|
Article: Abraxis Health Dedicates State of the Art Nanotechnology & Biologics Facility in Phoenix, Arizona.
- Article from:
- Business Wire
- Article date:
- November 5, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
-Flagship Facility Compliant with Worldwide Nanobiologics Regulatory Requirements-
LOS ANGELES -- Abraxis Health, a fully-integrated personalized healthcare division of Abraxis BioScience, Inc. (NASDAQ:ABII), today announced the dedication of its new manufacturing facility in Phoenix, Arizona. The state of the art biopharma manufacturing plant represents a $70 million investment by LA-based Abraxis, and will create up to 200 high tech jobs. The new facility will manufacture ABRAXANE([R]), the first solvent-free chemotherapy treatment option for metastatic breast cancer, which was developed using Abraxis BioScience's proprietary nab([R]) technology platform. The ...